MedPath
NMPA Approval

酞丁安

国药准字H33021477

January 18, 2021

Drug Information

酞丁安

原料药

化学药品

January 18, 2021

Company Information

Applicant Company

Manufacturing Company

浙江省常山工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酞丁安 - NMPA 批准文号 | MedPath